Recommendations and best practices for reference standards and reagents used in bioanalytical method validation
Related Experiment Video
Updated: May 3, 2026

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
Joseph F Bower1, Jennifer B McClung, Carl Watson
1Covance Laboratories Inc., 3635 Concorde Parkway, Suite 100, Chantilly, Virginia, 20151, USA, joseph.bower@covance.com.
Abstract:
The continued globalization of pharmaceutics has increased the demand for companies to know and understand the regulations that exist across the globe. One hurdle facing pharmaceutical and biotechnology companies developing new drug candidates is interpreting the current regulatory guidance documents and industry publications associated with bioanalytical method validation (BMV) from each of the different agencies throughout the world. The objective of this commentary is to provide our opinions on the best practices for reference standards and key reagents, such as metabolites and internal standards used in the support of regulated bioanalysis based on a review of current regulatory guidance documents and industry white papers for BMV.
More Related Videos
04:50Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research
Published on: August 4, 2023
11:25Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis
Published on: July 11, 2014
Related Concept Videos
Data Validation
Key parameters for method validation include:
Development of Analytical Methods
Clinically Relevant Drug Product Specifications: Methods of Establishment
In Vitro Drug Release Testing: Overview, Development and Validation
Standard Solutions
Therapeutic Drug Monitoring: Drug Analysis Methods